Cheap drug journey home

 Cheap drug prices journey home
department for several years, as many as dozens of large-scale drug price cut did not win much applause, and to start the year 2008, a small range of pharmaceutical prices is unusually get a lot of cheers. This show was great difference in the return of people to look forward to feeling cheap drugs, but also tell people a reasonable drug prices, the desire for rational drug use. In search of cheap drugs regression process, people began to think about the underlying hidden mechanisms, institutional shortcomings, more rational thinking and actions also will be his breakthrough.
unexpected applause
2008 beginning of this year, a small adjustment of drug prices actually won a lot of applause.
January 7, the National Development and Reform Commission released the first 25 drug price adjustment notice is different from the past, this price adjustment to increase drug prices based. glucose, polymyxin, rifampin 26 varieties 47 standard drugs increase the maximum retail price varies, nearly three times the maximum increase.
price adjustment there hippurate methenamine drugs, tegafur, batroxobin, cytochrome c, Doxofylline, anti-rabies serum, isoproterenol, and the infusion of methyl violet solution (potassium chloride, glucose, sodium lactate) and so on. These drugs most commonly used drugs people.
Previously, from 1998, the first time the former State Development Planning Commission drug prices opened the curtain, by 2007, 24 have been conducted to adjust drug prices. In particular, after 2000, adjusted to a significant reduction in drug prices has always been the main theme, involving more than 2400 kinds of medicine, covering almost all the government pricing drugs. But The prices this year drugs with different response is substantial drug prices artificially high drug prices is always difficult to get rid of the cross-examination.
dedicated people to cheer a price increase, yet the cross-examination thrown prices, why?
pharmaceutical analyst with CITIC Securities Analysis, said National Development and Reform Commission earlier because some people used the drug pricing is low, in the case of the general rise of raw materials, many companies difficult to support, have stopped. in the new medical reform and the new management system, the expected price of drugs under the drug price adjustments to improve the low-cost generic drugs and drug price-based, which seems to presage the coming of the new trend of drug price adjustment. This price adjustment policy will be conducive to the sound development of the industry, drug production quality and cheap price business interests will be protected, people will benefit.
Indeed, the country in order to improve low-cost generic drugs and drug prices 25 times based drug price adjustment is This produced a large background: the introduction of public health reform and the establishment of national essential drug system expectations. whether it is health reform program has been established system, the carrier can not do without drugs, of which low-cost generic drugs and medicine will undoubtedly play a more specific role.
this, the media believe that the small-scale drug prices, Cheap drugs information disease drugs, there is no distinction or distinction poor. In the interview, so often portrayed cheap drugs, generic drugs: a reasonable or low price, clinical common, and effective.
reason why people are shouting change the packaging, formulation, suddenly become a , gatifloxacin 61, ceftazidime 59 hh thousand kinds of drugs dollars of norfloxacin composition unchanged, another package to 100 yuan a box into a new drug; only 0.03 per tablet of aspirin, renamed the Beijing Sport Medicine
Pat Li Lei, director of economic research center, said: clinical needs. species of the shortage of cheap drugs.
Although the number of parties have differences, but an indisputable fact is: people need some cheap good clinical medicine is about to or have no access to the.
Enterprise inappropriate Lei Feng different types of drugs cheap drugs set the standard, the Japanese set the standard treatment costs less than the price of drugs not on the minimum retail sale price not lower than the set standard prices, the price is too low for some species is also appropriate raising prices.
These measures eased to some extent, production, operating low-cost drugs, but the price is too low, even if the implementation of high slip and various preferential policies, the implementation of the fare increase is still well below the amount the high price of drugs with low slip, low-cost drug market share continues to shrink.
the face of the disappearance of cheap drugs, if only the board hit him in the pharmaceutical manufacturing enterprise, it becomes unfair. or even a loss in the small profit margins under pressure , expect the market to act as life-saving business, contribution to the point where the marginal product as long as a suitable mm marginal contribution, there is no profit enterprises production. some raw materials such as nitroglycerin, rose from 800 yuan to 2,800 yuan, the enterprise does not produce, and this drug is the first aid treatment of heart disease specific. Therefore, the low-cost drugs Ye Hao, Ye Hao classical medicine, which should protect. the government needs to consider from the system up, and now can not explain the production can also be produced later.
pulse Beijing Qin Bo, President of Pharmaceutical Science and Technology Development happened to the cheap drugs known as With the heat response, may be dead within 20 minutes. This high-risk products, there needs high-tech, put out a lot of money to produce products in the market selling price is less than some of mineral water. even his in Anhui Wo wholesale prices actually have seen a bit of a zero.
Evaluation Center NDRC official drug prices drug prices is called Although the state has repeatedly adjust drug prices, there was a lot of cheap quality and cheap drugs for profit is not high and no one willing to produce, and some sales of high prices of drugs have emerged better and better, .
br> market economy is not a panacea, price leverage is not a panacea. for several years, dozens of price adjustment, so that people recognize the fact that: the price lever can not rely solely on cheap drugs block the return of leveraging the iron gate.
from the system level mechanisms to consider cheap drugs Cheap drugs are a reflection of the deep-rooted problems of rational thinking and actions in his breakthrough.
save the cheap place to practice medicine
way into thinking about the inevitable choice of all parties. Although people know that the way out is by no means single but a number of options, but a condition is inevitable and indispensable, that is, the government should have a.
Shanghai: Cheap drugs and protect the price of the so-called kinds of protection mechanisms and the government, enterprises and other low-cost multi-drug security cooperation, an innovative system to enter the market. health department listed in the directory of cheap drugs, the drugs are directly linked to the online publicity, set drug prices is not limited to, the intention of the enterprises declared himself the right price. a price department has received preliminary approval. Once the first batch of low-cost drugs, shortage of drugs and people has become a commonly used drug information on a permanent work in Shanghai.
Guangxi: The cheaper drug production subsidies to enterprises on January 15 this year, Guangxi Zhuang Autonomous Region Food and Drug Administration decided to start this year in the region establishment of basic drugs. First of all the health departments to record from the doctor to select the most common and most hair disease, under the premise of safety, bringing together experts selected the basic treatment of these diseases, cheap medicines, and work out the directory. Then to mobilize enterprises in accordance with the basic drug or the directory specified in the production of cheap drugs. If the business is loss-making production, may be considered by government subsidies.
Ningbo: Cheap drugs the hospital implemented the use of subsidies
1 10 May, Ningbo, Zhejiang Province City departments co-signed active use of cheap drugs.
from drug distribution point of view, the pharmaceutical market by the manufacturers, distribution companies, hospitals and pharmacies and patients constitute the four aspects of circulation and supply and demand. Once the production, distribution and use all or part of the three links lack of enthusiasm, even though patients in need of cheap medicines will gradually disappear. Only when these three areas are active when the supply of cheap drugs will be sent to the hands of patients. Whether to increase drug prices, government subsidies to promote production, protect the price mechanism into the hospital, or hospital benefits increased use of cheaper drugs, and only these measures have been in every aspect of improving and implementing the policy, it could set foot on the back of cheap drugs way.
clinical value in the pricing factors
2007 At the beginning of China's National Development and Reform Commission by Price Association, organized a questions to be answered are:
cheap drugs which should have the characteristics and conditions? how to define? how to manage?
Shanghai to address the shortage of cheap drugs measures taken?
shortage of drugs are the first clinical What? whether these drugs are cheap medicines? shortage of reasons for that?
the current shortage of medicines which have been restored supply? clinical evaluation of how?
in dealing with the shortage of cheap drugs in the practice of what their feelings and experiences? The key factor to solve this problem what?
design can be seen from the problems, the National Development and Reform Commission and the pharmaceutical industry, the drug price control department of the concern about where to save cheap drugs. Shanghai Pharmaceutical Industry Association President Chen Hui say their views. He said a large variety of drugs and small species without distinction, then some small difference between product price ratio can not, can not fit all. The state should manage the essential drug list, government pricing drugs not to tender part of the loss of scarce to consider the variety of raw materials rise, costs of environmental protection requirements and other factors, the pharmaceutical industry are related to people's health in specific industries, the government should provide policy support environment.
national levels of government more and more voices and actions. Health Minister Chen Zhu in the thirty-first session of the NPC Standing Committee to make establish a basic drug production and supply system, the implementation of centralized procurement tender point directly to the production or distribution, etc., to ensure the production and supply of essential drugs, improve the drugs reserve system to protect the people of basic drugs. Chen Zhu said that public hospitals to phase out the drug mechanism of subsidizing hospitals, lower drug prices. to increase financial assistance, an appropriate increase in price of medical services and other measures to improve the compensation mechanisms for public hospitals.
the Ministry of Health in the implementation of hospital management activities, prescription drug sampling systems and the rational evaluation system to be implemented in medical institutions in general . Reporter interview discovered in Fujian, more and more publicity monthly basic hospital drug use situation began to focus on monitoring the use of a large quantity of drugs are a doctor or departments will be made public. put an end to the has become the goal of medical institutions in their efforts.
State Food and Drug Administration revised the higher demand, in the past that disappear or hold down prices of the phenomenon will be changed.
which return with cheap drugs of good information is the most direct, the National Development and Reform Commission is exploring the clinical value of the drugs included in the pricing factors into account drugs effectively mm , safety, quality control and other factors, including degree of innovation, production and operating costs, market supply and demand, international comparisons and references.
policy of relying on this measure is that drug prices in the future management direction of reform will be mainly concentrated in the following areas: the introduction of patented drugs, generic drug classification system, improve the classification standards; implementation of rate control flow of the post, regulate the market price behavior; degree of innovation, the cost of implementing a differential rate, margin control; for serious oversupply Inhibition of generic pharmaceuticals to pricing policy; for cheap drugs, mainly at the lower cost of essential drugs to take, given the price to encourage and promote the availability and use of cheap drugs; reform and price adjustment policy to increase the predictability of policy adjustment ; for some special re-approved drug price management.

2007 年 11 the long way home 16, the State Development and Reform Commission, Ministry of Health and State Food and Drug Administration jointly issued the first batch of the 10 countries identified cheap drug manufacturing enterprises, and approved 18 varieties of cheap drugs listed. from drug varieties of screening, the determination of the manufacturer to limit drug prices and supply and use of the direction of the requirements to become the head of the Ministry of joint action, the Commission , the Council is more a rare coordinated action.
analysts believe that the 18 varieties of cheap drugs approved for marketing is the government department or joint control of essential drugs cheap drug prices, supply and use of a ;. for the further expansion of cheap drugs Drug agencies in the tender bidding process; package must clear national retail price maintenance; Drug Administration Department is working with the Ministry of Finance and other departments, to formulate preferential policies for taxation of drugs.
State Food and Drug Administration policies and regulations Yan Jiangying, deputy director, said the council will work with the Ministry of Health, the National Development and Reform Commission for the listing of cheap drugs to do something about the situation, the corresponding results of the investigation will be promptly announced to the public later. Drug Administration Department will be based on essential drugs list and rural and urban community drug demand, the first published summary of pharmaceutical experience, based on the second and third cases designated announced the production of cheap drugs.
executive vice president of China Association of Pharmaceutical Commerce Zhu Changhao that basic drug system should be introduced, to support national policy. essential medicines directory and solid, and cheap drugs all enter the directory, so as to ensure that enterprises of production and supply of cheap drugs.
in our health system, health care system and pharmaceutical distribution system has not fundamentally changed before, relying solely on one part does not fundamentally solve the problem of cheap drugs. Beijing Medical Health Pat Li Lei, director of economic research center that, in the national policy level, this relates to the pharmaceutical industry, people's livelihood strategies industries, not a scientific, sustainable, healthy and coordinated policy environment.
beginning of the year is encouraging drug prices convey information, but thus come to a ;'s too early.
cheap drugs back, there is still a long way to go.
link cheap drugs disappear
four reasons
Wang Tianjin University and Tianjin Matt Price Bureau, etc. were conducted at the end of 2007, a survey analysis that led to the disappearance of cheap drugs There are four main reasons:
mm production process is highly competitive. China has more than 4,000 pharmaceutical manufacturers, clinical widely used varieties of the same hundreds of manufacturers in the same production. such as cimetidine more than 800 types of batch preparations, ciprofloxacin has more than 500, more than 800 Liuweidihuang hh enterprises to survive the pressure of the pharmaceutical market is efficient, high-quality, low cost competition into a formulations transformation of disintegrating tablets, effervescent tablets, sustained-release tablets, controlled release tablets and other high dosage; to traditional Chinese medicine tablets, granules, oral liquid transformation of injection, pills, Pill and other high dosage.
mm distribution companies under the dual pressures of .2005, the State Development and Reform Commission and the provincial department in charge of an appropriate increase in price to enter the Retail prices for many years without making adjustments. and also provides centralized drug purchasing a new tender bid price shall not exceed the previous year's bid price accepted by patients are afraid of cheap drugs to easily adjust the market price. circulation in the face of brutal market competition and operating the dual pressures of rising costs, once breaking the break-even point, it will naturally give up low-cost drugs.
mm hospitals, pharmacies to seek maximum benefits and the lack of constraints. Admittedly, most of the non-profit medical organization has always treated effect the first place, as long as patients need, drugs are equal without discrimination, which is now part of the curative effect of a few cents a tablet and the injection of a few cents on the large-scale use is still the main reason for the market. The problem lies in the alternative on stronger drugs: treatment of the same disease there are several or even dozens of drugs to choose from, but each drug has been made hundreds of dozens of manufacturers of dosage forms, specifications. in the current operating mode of hospitals and doctors Drugs linked to income and sales system, even if the effect of factors into account, low-cost high-priced medicine also first in the drug sales. Meanwhile, China has yet to establish more stringent, standardized system for the clinical treatment guidelines and drug supervision and inspection system to regulate the type and sequence of clinical medicine, clinical medicine arbitrary, for some units to seek maximum benefits provided for convenience.
mm were not self-consumption or consumption concept is wrong. due to lack of medical expertise and pharmaceutical prices, quality, efficacy comparative information, the patient can not choose to use cheap drugs: prescription drug market entirely by the medical establishment monopoly, the patient must follow the doctor's prescription drugs; patients in the choice of treatment of colds, coughs, gastrointestinal discomfort and other minor diseases, non-prescription drugs, the still very easy to misled by the sales staff. Meanwhile, there are some patients blindly expensive medicine, imported drugs, the efficacy of drug joint venture, individual access to health insurance, price-insensitive patients, the blind pursuit of high standards of medicine.